Eli Lilly and Company
LLY
$839.96
$105.0614.30%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 101.39% | 1,790.42% | 68.27% | 66.77% | 13.01% |
| Total Depreciation and Amortization | 25.05% | 13.58% | 13.13% | 10.57% | 3.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -169.25% | 119.13% | 21.49% | 294.53% | 62.40% |
| Change in Net Operating Assets | 29.86% | -101.24% | -66.52% | -1,167.15% | -284.88% |
| Cash from Operations | 893.14% | 69.53% | 132.03% | -32.62% | -118.76% |
| Capital Expenditure | -39.73% | -39.20% | -65.92% | -47.54% | -113.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -219.16% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.55% | -25.77% | -109.39% | -842.36% | -600.17% |
| Cash from Investing | 34.33% | -30.00% | -378.92% | -70.96% | -209.94% |
| Total Debt Issued | -100.00% | 5,018.14% | -- | 63.00% | 1,988.37% |
| Total Debt Repaid | -- | -306.23% | -- | -247.45% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -14.75% | -15.18% | -15.19% | -14.94% | -15.12% |
| Other Financing Activities | -43.99% | -595.59% | 48.72% | -38.72% | -130.66% |
| Cash from Financing | -106.36% | -63.06% | 250.52% | -175.50% | 410.56% |
| Foreign Exchange rate Adjustments | -431.40% | 4,181.13% | -747.83% | -243.15% | 200.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -122.98% | 146.35% | 189.66% | -124.23% | 179.54% |